Dr. Michael Jewett is a Professor of Bioengineering at Stanford University. He received his B.S. from UCLA and PhD from Stanford University, both in Chemical Engineering. He completed postdoctoral studies at the Center for Microbial Biotechnology in Denmark and the Harvard Medical School. Jewett was also a guest professor at the Swiss Federal Institute of Technology (ETH Zurich). His research group focuses on advancing synthetic biology research to support planet and societal health, with applications in medicine, manufacturing, sustainability, and education.

Dr. Matteo A. Molè, PhD, is an Assistant Professor in the Department of Obstetrics and Gynecology at Stanford University. He is a member of the Division of Reproductive, Stem Cell and Perinatal Biology, as well as the Dunlevie Maternal-Fetal Medicine Center for Discovery, Innovation and Clinical Impact.

Dr. Vivek Buch is a neurosurgeon with fellowship training in epilepsy, functional, and minimally invasive neurosurgery. He is a clinical assistant professor in the Department of Neurosurgery of Stanford University School of Medicine.

Dr. Daniel Delitto is a board certified complex general surgical oncologist with a focus on conditions of the liver, pancreas, and stomach. He is an assistant professor in Stanford Medicine’s Department of Surgery.

Dr. Florentine Rutaganira uses choanoflagellates - the closest living single-celled relatives to animals - to study the origin of animal cell communication. Dr. Rutaganira applies chemical, genetic, and cell biological tools to probe choanoflagellate cell-cell communication, with implications for understanding not only animal cell signaling, but also the origin of multicellularity in animals.

Dr. Nathan Reticker-Flynn is a Biomedical Engineer and tumor immunologist working at the interfaces of cancer metastasis, tumor evolution, adaptive immunity, and immuno-oncology. His work employs mouse models and systems biology and genetic engineering to investigate interactions between tumors and the immune system during cancer metastasis. He performed his PhD work in Biomedical Engineering with Dr. Sangeeta Bhatia at MIT where he studied glycobiology and ECM interactions during cancer metastasis and his postdoctoral studies with Dr.

Dr. Ryann Fame, PhD, joined the faculty at Stanford University in 2022. Following her undergraduate degree in Biology and Chemistry at the College of William & Mary, Dr. Fame completed a PhD in Molecular and Cellular Biology at Harvard University. She conducted postdoctoral fellowships at The Whitehead Institute for Biomedical Research at MIT and at Boston Children’s Hospital Pathology Department.  As a stem cell and developmental molecular biologist, Dr.

Dr. Ruth Huttenhain's group deciphers how G protein-coupled receptors decode extracellular cues into dynamic and context-specific cellular signaling networks to elicit diverse physiologic responses. They exploit quantitative proteomics to capture the spatiotemporal organization of signaling networks combined with functional genomics to study their impact on physiology.

As a physician-scientist, Dr. Anusha Kalbasi leads both clinical trials and laboratory research at the intersection of cancer and immunology.

Dr. Lunn is a physician-scientist investigating sexual and gender minority health and utilizing existing and emerging technologies to characterize the health and well-being of these underrepresented and vulnerable populations.